Search Results - "Programmed cell death protein-1 inhibitors"

Clinical Effectiveness and Safety of Transarterial Chemoembolization: Hepatic Artery Infusion Chemotherapy Plus Tyrosine Kinase Inhibitors With or Without Programmed Cell Death Protein-1 Inhibitors for Unresectable Hepatocellular Carcinoma—A Retrospective Study

Chen, Yue, Jia, Luyao, Li, Yu, Cui, Wenhao, Wang, Jukun, Zhang, Chao, Bian, Chunjing, Wang, Zhenshun, Lin, Dongdong, Luo, Tao^{Aff1, IDs10434024159332_cor10}

Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy

Xuehan Shen, Wei Yan, Erlei Zhang, Zhiwei Zhang, Zunyi Zhang, Hanhua Dong

electronic resource

View item

Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma

Xiao, Yongqiang^{Aff1, Aff2, Aff3}, Deng, Wei, Luo, Laihui, Zhu, Guoqing, Xie, Jin, Liu, Yu, Wan, Renhua, Wen, Wu, Hu, Zhigao^{Aff1, IDs1288502412355x_cor9}, Shan, Renfeng^{Aff1, IDs1288502412355x_cor10}

Efficiency and safety of HAIC combined with lenvatinib and tislelizumab for advanced hepatocellular carcinoma with high tumor burden: a multicenter propensity score matching analysis

Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao

electronic resource

View item; View item

Community characteristics and relationship between gut microbiota and intratumoral microbiota in hepatocellular carcinoma

Huangpeng Lin, Zexian Ma, Jin Li, Heping Zhu, Xuefeng Huang, Huimin Chen, Liang Tu, Yifan Lian, Yongjie Su

electronic resource

View item; View item

Hedgehog Pathway and Programmed Cell Death Protein-1 Inhibitors for Advanced Basal Cell Carcinoma

Babette J.A. Verkouteren, An K.L. Reyners, Maureen J.B. Aarts, Klara Mosterd

electronic resource

View item; View item

Efficacy and safety of transarterial chemoembolization plus lenvatinib combined with PD-1 inhibitors versus transarterial chemoembolization plus lenvatinib for unresectable hepatocellular carcinoma: a meta-analysis

Yue Chen, Luyao Jia, Yu Li, Wenhao Cui, Jukun Wang, Chao Zhang, Chunjing Bian, Tao Luo

electronic resource

View item; View item

Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bladder urothelial cancer

Chao Xu, Wen Zou, Lei Zhang, Ran Xu, Yuan Li, Yeqian Feng, Runtian Zhao, Yinhuai Wang, Xianling Liu, Jingjing Wang

electronic resource

View item; View item

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab compared with chemotherapy alone and chemoradiotherapy for locally advanced esophageal squamous cell cancer

Baihua Zhang, Hongbo Zhao, Xun Wu, Lianghui Gong, Desong Yang, Xu Li, Xiaoyan Chen, Jigang Li, Wenxiang Wang, Jie Wu, Qin Xiao

electronic resource

View item; View item

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.